{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T08:09:49Z","timestamp":1758960589734},"reference-count":39,"publisher":"Elsevier BV","issue":"13","license":[{"start":{"date-parts":[[2008,3,1]],"date-time":"2008-03-01T00:00:00Z","timestamp":1204329600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2008,3]]},"DOI":"10.1016\/j.vaccine.2008.01.024","type":"journal-article","created":{"date-parts":[[2008,2,5]],"date-time":"2008-02-05T13:23:55Z","timestamp":1202217835000},"page":"1664-1674","source":"Crossref","is-referenced-by-count":20,"title":["Relative immunogenicity and protection potential of candidate Yersinia Pestis antigens against lethal mucosal plague challenge in Balb\/C mice"],"prefix":"10.1016","volume":"26","author":[{"given":"Shixia","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Swati","family":"Joshi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Innocent","family":"Mboudjeka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fangjun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tzufan","family":"Ling","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jon D.","family":"Goguen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shan","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"May (Suppl.)","key":"10.1016\/j.vaccine.2008.01.024_bib1","doi-asserted-by":"crossref","first-page":"S26","DOI":"10.1093\/infdis\/129.Supplement_1.S26","article-title":"Plague immunization. 3. Serologic response to multiple inoculations of vaccine","volume":"129","author":"Marshall","year":"1974","journal-title":"J Infect Dis"},{"issue":"May (Suppl.)","key":"10.1016\/j.vaccine.2008.01.024_bib2","doi-asserted-by":"crossref","first-page":"S19","DOI":"10.1093\/infdis\/129.Supplement_1.S19","article-title":"Plague immunization. II. Relation of adverse clinical reactions to multiple immunizations with killed vaccine","volume":"129","author":"Marshall","year":"1974","journal-title":"J Infect Dis"},{"issue":"July","key":"10.1016\/j.vaccine.2008.01.024_bib3","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1016\/S0264-410X(96)00303-9","article-title":"A sub-unit vaccine elicits IgG in serum, spleen cell cultures and bronchial washings and protects immunized animals against pneumonic plague","volume":"15","author":"Williamson","year":"1997","journal-title":"Vaccine"},{"issue":"September\u2013October","key":"10.1016\/j.vaccine.2008.01.024_bib4","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1021\/bp050098r","article-title":"Design and testing for a nontagged F1-V fusion protein as vaccine antigen against bubonic and pneumonic plague","volume":"21","author":"Powell","year":"2005","journal-title":"Biotechnol Prog"},{"issue":"November","key":"10.1016\/j.vaccine.2008.01.024_bib5","doi-asserted-by":"crossref","first-page":"4580","DOI":"10.1128\/IAI.64.11.4580-4585.1996","article-title":"Recombinant V antigen protects mice against pneumonic and bubonic plague caused by F1-capsule-positive and -negative strains of Yersinia pestis","volume":"64","author":"Anderson","year":"1996","journal-title":"Infect Immun"},{"issue":"October (4\u20135)","key":"10.1016\/j.vaccine.2008.01.024_bib6","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/S0264-410X(00)00159-6","article-title":"A single dose sub-unit vaccine protects against pneumonic plague","volume":"19","author":"Williamson","year":"2000","journal-title":"Vaccine"},{"issue":"October (4)","key":"10.1016\/j.vaccine.2008.01.024_bib7","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1006\/mpat.2000.0385","article-title":"The F1 and V subunit vaccine protects against plague in the absence of IL-4 driven immune responses","volume":"29","author":"Elvin","year":"2000","journal-title":"Microb Pathog"},{"issue":"July (30)","key":"10.1016\/j.vaccine.2008.01.024_bib8","doi-asserted-by":"crossref","first-page":"4175","DOI":"10.1016\/S0264-410X(01)00163-3","article-title":"Vaccination against bubonic and pneumonic plague","volume":"19","author":"Titball","year":"2001","journal-title":"Vaccine"},{"issue":"June (6)","key":"10.1016\/j.vaccine.2008.01.024_bib9","doi-asserted-by":"crossref","first-page":"3598","DOI":"10.1128\/IAI.73.6.3598-3608.2005","article-title":"Human immune response to a plague vaccine comprising recombinant F1 and V antigens","volume":"73","author":"Williamson","year":"2005","journal-title":"Infect Immun"},{"issue":"4","key":"10.1016\/j.vaccine.2008.01.024_bib10","doi-asserted-by":"crossref","first-page":"1922","DOI":"10.1128\/IAI.67.4.1922-1928.1999","article-title":"Immune response to Yersinia outer proteins and other Yersinia pestis antigens after experimental plague infection in mice","volume":"67","author":"Benner","year":"1999","journal-title":"Infect Immun"},{"issue":"June (3)","key":"10.1016\/j.vaccine.2008.01.024_bib11","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1128\/IAI.48.3.676-685.1985","article-title":"Immune response to plasmid- and chromosome-encoded Yersinia antigens","volume":"48","author":"Mazza","year":"1985","journal-title":"Infect Immun"},{"issue":"November (5084)","key":"10.1016\/j.vaccine.2008.01.024_bib12","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1126\/science.1439793","article-title":"A surface protease and the invasive character of plague","volume":"258","author":"Sodeinde","year":"1992","journal-title":"Science"},{"issue":"December (4)","key":"10.1016\/j.vaccine.2008.01.024_bib13","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1128\/MMBR.62.4.1315-1352.1998","article-title":"The virulence plasmid of Yersinia, an antihost genome","volume":"62","author":"Cornelis","year":"1998","journal-title":"Microbiol Mol Biol Rev"},{"issue":"3","key":"10.1016\/j.vaccine.2008.01.024_bib14","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1007\/BF02818610","article-title":"The Yersinia Yop virulon, a bacterial system to subvert cells of the primary host defense","volume":"43","author":"Cornelis","year":"1998","journal-title":"Folia Microbiol (Praha)"},{"issue":"1","key":"10.1016\/j.vaccine.2008.01.024_bib15","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1128\/CMR.10.1.35","article-title":"Yersinia pestis\u2014etiologic agent of plague","volume":"10","author":"Perry","year":"1997","journal-title":"Clin Microbiol Rev"},{"issue":"November (21)","key":"10.1016\/j.vaccine.2008.01.024_bib16","doi-asserted-by":"crossref","first-page":"5812","DOI":"10.1002\/j.1460-2075.1996.tb00968.x","article-title":"The YopB protein of Yersinia pseudotuberculosis is essential for the translocation of Yop effector proteins across the target cell plasma membrane and displays a contact-dependent membrane disrupting activity","volume":"15","author":"Hakansson","year":"1996","journal-title":"EMBO J"},{"issue":"October (19)","key":"10.1016\/j.vaccine.2008.01.024_bib17","doi-asserted-by":"crossref","first-page":"5191","DOI":"10.1002\/j.1460-2075.1996.tb00904.x","article-title":"Status of YopM and YopN in the Yersinia Yop virulon: YopM of Y. enterocolitica is internalized inside the cytosol of PU5-1.8 macrophages by the YopB, D,N delivery apparatus","volume":"15","author":"Boland","year":"1996","journal-title":"EMBO J"},{"issue":"September (6)","key":"10.1016\/j.vaccine.2008.01.024_bib18","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1111\/j.1365-2958.2005.04790.x","article-title":"The Yersinia pestis type III secretion needle plays a role in the regulation of Yop secretion","volume":"57","author":"Torruellas","year":"2005","journal-title":"Mol Microbiol"},{"issue":"January (1)","key":"10.1016\/j.vaccine.2008.01.024_bib19","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1128\/IAI.61.1.71-80.1993","article-title":"YopB and YopD constitute a novel class of Yersinia Yop proteins","volume":"61","author":"Hakansson","year":"1993","journal-title":"Infect Immun"},{"issue":"February (6\u20137)","key":"10.1016\/j.vaccine.2008.01.024_bib20","first-page":"455","article-title":"The Yersinia Ysc-Yop virulence apparatus","volume":"291","author":"Cornelis","year":"2002","journal-title":"Int J Med Microbiol"},{"issue":"May (3)","key":"10.1016\/j.vaccine.2008.01.024_bib21","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1046\/j.1365-2958.1996.5251051.x","article-title":"The Yersinia YpkA Ser\/Thr kinase is translocated and subsequently targeted to the inner surface of the HeLa cell plasma membrane","volume":"20","author":"Hakansson","year":"1996","journal-title":"Mol Microbiol"},{"issue":"July (1)","key":"10.1016\/j.vaccine.2008.01.024_bib22","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.pep.2005.02.016","article-title":"Yersinia pestis Yop secretion protein F: purification, characterization, and protective efficacy against bubonic plague","volume":"42","author":"Swietnicki","year":"2005","journal-title":"Protein Expr Purif"},{"issue":"1","key":"10.1016\/j.vaccine.2008.01.024_bib23","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/1471-2180-5-38","article-title":"Immunization of mice with YscF provides protection from Yersinia pestis infections","volume":"5","author":"Matson","year":"2005","journal-title":"BMC Microbiol"},{"issue":"December (5)","key":"10.1016\/j.vaccine.2008.01.024_bib24","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/S0168-6445(01)00067-5","article-title":"Bacterial plasminogen activators and receptors","volume":"25","author":"Lahteenmaki","year":"2001","journal-title":"FEMS Microbiol Rev"},{"issue":"August (1\u20132)","key":"10.1016\/j.vaccine.2008.01.024_bib25","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S0014-5793(01)02775-2","article-title":"The Pla surface protease\/adhesin of Yersinia pestis mediates bacterial invasion into human endothelial cells","volume":"504","author":"Lahteenmaki","year":"2001","journal-title":"FEBS Lett"},{"issue":"July (1)","key":"10.1016\/j.vaccine.2008.01.024_bib26","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.ijmm.2004.01.003","article-title":"The omptin family of enterobacterial surface proteases\/adhesins: from housekeeping in Escherichia coli to systemic spread of Yersinia pestis","volume":"294","author":"Kukkonen","year":"2004","journal-title":"Int J Med Microbiol"},{"issue":"Jan (5811)","key":"10.1016\/j.vaccine.2008.01.024_bib27","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1126\/science.1137195","article-title":"A plasminogen-activating protease specifically controls the development of primary pneumonic plague","volume":"315","author":"Lathem","year":"2007","journal-title":"Science (New York, NY)"},{"issue":"March (3)","key":"10.1016\/j.vaccine.2008.01.024_bib28","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1128\/IAI.67.3.1533-1537.1999","article-title":"Protective efficacy of recombinant Yersinia outer proteins against bubonic plague caused by encapsulated and nonencapsulated Yersinia pestis","volume":"67","author":"Andrews","year":"1999","journal-title":"Infect Immun"},{"issue":"April (6982)","key":"10.1016\/j.vaccine.2008.01.024_bib29","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1038\/nature02463","article-title":"A DNA vaccine induces SARS coronavirus neutralization and protective immunity in mice","volume":"428","author":"Yang","year":"2004","journal-title":"Nature"},{"issue":"February (3)","key":"10.1016\/j.vaccine.2008.01.024_bib30","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1128\/JVI.79.3.1906-1910.2005","article-title":"Identification of two neutralizing regions on the severe acute respiratory syndrome coronavirus spike glycoprotein produced from the mammalian expression system","volume":"79","author":"Wang","year":"2005","journal-title":"J Virol"},{"issue":"May (9)","key":"10.1016\/j.vaccine.2008.01.024_bib31","doi-asserted-by":"crossref","first-page":"4433","DOI":"10.1128\/JVI.78.9.4433-4443.2004","article-title":"Smallpox DNA vaccine protects nonhuman primates against lethal monkeypox","volume":"78","author":"Hooper","year":"2004","journal-title":"J Virol"},{"issue":"September (25\u201326)","key":"10.1016\/j.vaccine.2008.01.024_bib32","doi-asserted-by":"crossref","first-page":"3348","DOI":"10.1016\/j.vaccine.2004.02.036","article-title":"A DNA vaccine producing LcrV antigen in oligomers is effective in protecting mice from lethal mucosal challenge of plague","volume":"22","author":"Wang","year":"2004","journal-title":"Vaccine"},{"issue":"January (2)","key":"10.1016\/j.vaccine.2008.01.024_bib33","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1089\/aid.1998.14.151","article-title":"Immunogenicity of DNA vaccines expressing human immunodeficiency virus type 1 envelope glycoprotein with and without deletions in the V1\/2 and V3 regions","volume":"14","author":"Lu","year":"1998","journal-title":"AIDS Res Hum Retroviruses"},{"issue":"October (10)","key":"10.1016\/j.vaccine.2008.01.024_bib34","doi-asserted-by":"crossref","first-page":"2749","DOI":"10.1128\/IAI.56.10.2749-2752.1988","article-title":"Plasminogen activator\/coagulase gene of Yersinia pestis is responsible for degradation of plasmid-encoded outer membrane proteins","volume":"56","author":"Sodeinde","year":"1988","journal-title":"Infect Immun"},{"issue":"October (10)","key":"10.1016\/j.vaccine.2008.01.024_bib35","doi-asserted-by":"crossref","first-page":"2743","DOI":"10.1128\/IAI.56.10.2743-2748.1988","article-title":"Genetic analysis of the 9.5-kilobase virulence plasmid of Yersinia pestis","volume":"56","author":"Sodeinde","year":"1988","journal-title":"Infect Immun"},{"issue":"May (21)","key":"10.1016\/j.vaccine.2008.01.024_bib36","doi-asserted-by":"crossref","first-page":"4531","DOI":"10.1016\/j.vaccine.2005.08.023","article-title":"Relative contributions of codon usage, promoter efficiency and leader sequence to the antigen expression and immunogenicity of HIV-1 Env DNA vaccine","volume":"24","author":"Wang","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2008.01.024_bib37","first-page":"355","volume":"29","author":"Lu","year":"1998","journal-title":"Methods Mol Med"},{"issue":"September (37)","key":"10.1016\/j.vaccine.2008.01.024_bib38","doi-asserted-by":"crossref","first-page":"38693","DOI":"10.1074\/jbc.M405217200","article-title":"Novel protein-protein interactions of the Yersinia pestis type III secretion system elucidated with a matrix analysis by surface plasmon resonance and mass spectrometry","volume":"279","author":"Swietnicki","year":"2004","journal-title":"J Biol Chem"},{"issue":"June (12)","key":"10.1016\/j.vaccine.2008.01.024_bib39","doi-asserted-by":"crossref","first-page":"7933","DOI":"10.1128\/JVI.79.12.7933-7937.2005","article-title":"Enhanced immunogenicity of gp120 protein when combined with recombinant DNA priming to generate antibodies that neutralize the JR-FL primary isolate of human immunodeficiency virus type 1","volume":"79","author":"Wang","year":"2005","journal-title":"J Virol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X08000832?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X08000832?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T13:40:41Z","timestamp":1588340441000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X08000832"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,3]]},"references-count":39,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2008,3]]}},"alternative-id":["S0264410X08000832"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2008.01.024","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2008,3]]}}}